In Finland, the research & development by business enterprise, pharmaceutical industry in constant ppp $ currently stands at 183.14 million, reflecting an increase of 3.23 million (1.8%) since 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Finland
No matching regions
Similar regions to Finland
Business R&D pharmaceutical in constant PPP $
More indicators for Finland
Government R&D in security as % of government support
2.13%
+0.15%
(2021)
Higher-education-finacing R&D financed by general university in local currency
7,358.96M
-629.04M
(2021)
R&D financed by rest of the world in local currency
10,499.15M
+729.15M
(2021)
Government R&D financed by rest of the world in local currency
927.92M
+41.92M
(2021)
Business R&D financed by rest of the world in local currency
7,201.34M
+403.34M
(2021)
Non-profit R&D growth rate
-12.04%
-11.84%
(2022)
Finland Business R&D pharmaceutical in constant PPP $ between 2008 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 183.14M | +3.23M |
| 2020 | 179.91M | +10.10M |
| 2019 | 169.82M | +10.13M |
| 2018 | 159.69M | -1.45M |
| 2017 | 161.14M | +3.19M |
| 2016 | 157.95M | +14.73M |
| 2015 | 143.21M | -7.58M |
| 2014 | 150.79M | +14.38M |
| 2013 | 136.41M | -22.75M |
| 2012 | 159.16M | +18.81M |
| 2011 | 140.36M | +10.54M |
| 2010 | 129.81M | -5.36M |
| 2009 | 135.18M | -4.93M |
| 2008 | 140.11M |